Detalles de la búsqueda
1.
Breast cancer early detection: A phased approach to implementation.
Cancer;
126 Suppl 10: 2379-2393, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32348566
2.
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
Breast Cancer Res Treat;
183(3): 749-757, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728860
3.
Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire.
Genet Mol Biol;
42(1 suppl 1): 232-237, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31170278
4.
Assessment of potential risk factors for breast cancer in a population in Southern Brazil.
Breast Cancer Res Treat;
169(1): 125-131, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29344741
5.
Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.
Genet Mol Biol;
39(2): 210-22, 2016 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27223485
6.
A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case-control study.
BMC Cancer;
14: 850, 2014 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25409685
7.
Exercise volume load in women with breast cancer: Study protocol for the ABRACE randomized clinical trial.
Contemp Clin Trials Commun;
31: 101053, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36589863
8.
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.
Ther Adv Med Oncol;
14: 17588359221141760, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601632
9.
Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.
JCO Glob Oncol;
7: 474-485, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822641
10.
Breast cancer survival in Brazil: How much health care access impact on cancer outcomes?
Breast;
54: 155-159, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33120081
11.
Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
JCO Glob Oncol;
6: 439-452, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32155091
12.
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
BMC Cancer;
9: 283, 2009 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19682358
13.
A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).
BMC Public Health;
9: 83, 2009 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19284670
14.
Body image (dis)satisfaction among low-income adult women.
Clin Nutr;
38(3): 1317-1323, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934132
15.
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
Cancer Lett;
261(1): 21-5, 2008 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-18248785
16.
Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
Clin Breast Cancer;
18(5): e797-e803, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29778786
17.
p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Fam Cancer;
17(2): 269-274, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28756477
18.
Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System.
J Glob Oncol;
3(3): 201-207, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28717761
19.
Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care.
Nat Med;
28(9): 1738-1739, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941378
20.
Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
Cancer Genet;
209(3): 97-106, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26823150